← Back to Search

Youth Engagement Strategy for Opioid Use Disorder

N/A

Recruiting

Led By Parissa J Ballard, PhD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 6

Awards & highlights

No Placebo-Only Group

Summary

This trial will test the feasibility, acceptability, and effectiveness of a Youth Engagement strategy to help prevent opioid misuse in a small pilot RCT. Up to 60 people will be recruited to compare effects on organization and individual-level outcomes.

Who is the study for?

This trial is for leaders or staff of North Carolina-based community organizations focused on opioid misuse prevention. These organizations should be ready and interested in incorporating Youth Engagement (YE) strategies, with the necessary resources to do so. Participants must speak English fluently. It also includes volunteers aged 16-29 engaged in these efforts. Organizations already highly involved in YE are excluded.

What is being tested?

The study tests a new strategy that involves youth more deeply in substance misuse prevention programs within community organizations. Phase 1 develops and tests this approach's feasibility; Phase 2 uses a small-scale randomized controlled trial to compare outcomes between groups using the YE strategy and those not using it.

What are the potential side effects?

Since this is an organizational-level intervention rather than a medical treatment, traditional side effects are not applicable. However, potential negative impacts could include increased workload for staff or possible resistance from individuals less receptive to changes in program structure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Perceived Usefulness of YE prevention

Perceived effectiveness, quality, reach, and usefulness of general prevention approaches

Retention Percentage of Youth/Young Adults in YE Prevention Programming

+1 more

Secondary study objectives

Youth/young adults: beliefs and intentions related to substance use

Youth/young adults: leadership and communication skills

Youth/young adults: meaningful social role

+3 more

Other study objectives

Exploratory--Perceived Usefulness of YE prevention, Qualitative

Exploratory--Perceived effectiveness, quality, reach, and usefulness of general prevention approaches, Qualitative

Exploratory--Reach of YE Prevention Efforts in the Community, Qualitative

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Phase 2 interventionExperimental Treatment1 Intervention

In this arm the study will implement an organization-level Youth Engagement prevention strategy by systematically incorporating Youth Engagement into prevention efforts in a community setting.

Group II: Phase 2 controlActive Control1 Intervention

This arm will receive no intervention. Control group organizations will continue their normal prevention strategy without the inclusion of a Youth Engagement component

Do I qualify?Apply below to find out